Macrocyclic beta-secretase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2004266605 (hide)

Owner Merck & Co., Inc.

Inventors Coburn, Craig; Vacca, Joseph P.; Stachel, Shawn J.

Agent Spruson & Ferguson

Pub. Number AU-A-2004266605

PCT Pub. Number WO2005/018545

Priority 60/495,667 14.08.03 US

Filing date 10 August 2004

Wipo publication date 3 March 2005

International Classifications

C07D 267/22 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 225/04 (2006.01) Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/018545 Priority application(s): WO2005/018545

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266612-Mitotic kinesin inhibitors

2004266603-(4-hydroxyphenyl)-1H-indole-3-carbalde hyde oxime derivative as estrogenic agents